Retrospective Study of COVID-19 on Reproductive Function

Summary

This multi-center, retrospective cohort study aimed to determine which factors are associated with ongoing pregnancy rates in infertile patients received ART treatments during the current outbreak of COVID-19 infection.Couples who underwent IVF-ET/ICSI-ET/FET due to infertility in the department of Reproductive Medicine from 2022-11-23 to 2023-01-07 were included. Patients who were infected with Coronavirus were observation groups; the infection status and clinical outcome were tracked. Patients who were not infected with Coronavirus were control groups.

Conditions

• COVID-19

Interventions

OTHER

no intervention

no intervention

Sponsors & Collaborators

• Jinling Hospital, China

  lead OTHER

Principal Investigators

• Bing Yao, PHD · Department of Reproductive Medicine, Jinling Hospital

• Li Chen, PHD · Department of Reproductive Medicine, Jinling Hospital

• Xiaojie Huang, PHD · Department of Reproductive Medicine, Xuzhou Maternal and Child Health Care Hospital

• Jiayi Ding, PHD · Department of Reproductive Medicine, Nantong Maternal and Child Health Care Hospital

• Qin Sun, MD · Department of Reproductive Medicine, Jinling Hospital

• Meiling Li, PHD · Department of Reproductive Medicine, Jinling Hospital

• Cheng Zhou, MD · Department of Reproductive Medicine, Jinling Hospital

• Xi Chen, MD · Department of Reproductive Medicine, Jinling Hospital

• Yuming Feng, MD · Department of Reproductive Medicine, Jinling Hospital

• Juanjuan Xu, MD · Department of Reproductive Medicine, Jinling Hospital

• Haiyan Fu, MD · Department of Reproductive Medicine, Jinling Hospital

• Cencen Wang, MD · Department of Reproductive Medicine, Jinling Hospital

• Hong Zhang, MD · Department of Reproductive Medicine, Jinling Hospital

• Lu Zheng, MD · Department of Reproductive Medicine, Jinling Hospital

• Yuxiu Liu, PHD · Department of Critical Care Medicine, Jinling Hospital

• Xiaofang Tan, MD · Department of Reproductive Medicine, Nantong Maternal and Child Health Care Hospital

• Yunxia Zhu, MD · Department of Reproductive Medicine, Xuzhou Maternal and Child Health Care Hospital

• Jueraitetibaike Kadiliya, PHD · Department of Reproductive Medicine, Jinling Hospital

• Zhichan Zou, MD · Department of Reproductive Medicine, Jinling Hospital

Eligibility

Min Age

20 Years

Max Age

42 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2023-01-20

Primary Completion

2023-03-30

Completion

2024-01-30

Countries

• China

Study Locations